Skip to main content

Advertisement

Log in

Safety and efficacy of prothrombin complex concentrate (PCC) for anticoagulation reversal in patients undergoing urgent neurosurgical procedures: a systematic review and metaanalysis

  • Review
  • Published:
Neurosurgical Review Aims and scope Submit manuscript

Abstract

Anticoagulant therapy poses a significant risk for patients undergoing emergency neurosurgery procedures, necessitating reversal with prothrombin complex concentrate (PCC) or fresh frozen plasma (FFP). Data on PCC efficacy lack consistency in this setting. This systematic review and metaanalysis aimed to evaluate efficacy and safety of PCC for anticoagulation reversal in the context of urgent neurosurgery. Articles from PubMed, Embase, and Cochrane databases were screened according to the PRISMA checklist. Adult patients receiving anticoagulation reversal with PCC for emergency neurosurgical procedures were included. When available, patients who received FFP were included as a comparison group. Pooled estimates of observational studies were calculated for efficacy and safety outcomes via random-effects modeling. Initial search returned 4505 articles, of which 15 studies met the inclusion criteria. Anticoagulants used included warfarin (83%), rivaroxaban (6.8%), phenprocoumon (6.1%), apixaban (2.2%), and dabigatran (1.5%). The mean International Normalized Ratio (INR) prePCC administration ranged from 2.3 to 11.7, while postPCC administration from 1.1 to 1.4. All-cause mortality at 30 days was 27% (95%CI 21, 34%; I2 = 44.6%; p-heterogeneity = 0.03) and incidence of thromboembolic events was 6.00% among patients treated with PCC (95%CI 4.00, 10.0%; I2 = 0%; p-heterogeneity = 0.83). Results comparing PCC and FFP demonstrated no statistically significant differences in INR reversal, mortality, or incidence of thromboembolic events. This metaanalysis demonstrated adequate safety and efficacy for PCC in the reversal of anticoagulation for urgent neurosurgical procedures. There was no significant difference between PCC and FFP, though further trials would be useful in demonstrating the safety and efficacy of PCC in this setting.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

Not applicable.

References

  1. Agarwal P, Abdullah KG, Ramayya AG, Nayak NR, Lucas TH (2018) A retrospective propensity score-matched early thromboembolic event analysis of prothrombin complex concentrate vs fresh frozen plasma for warfarin reversal prior to emergency neurosurgical procedures. Neurosurgery 82:877–886. https://doi.org/10.1093/neuros/nyx327

    Article  PubMed  Google Scholar 

  2. Allison TA, Lin PJ, Gass JA, Chong K, Prater SJ, Escobar MA, Hartman HD (2018) Evaluation of the use of low-dose 4-factor prothrombin complex concentrate in the reversal of direct oral anticoagulants in bleeding patients. J Intensive Care Med. https://doi.org/10.1177/0885066618800657

  3. Barillari G, Pasca S, Barillari A, De Angelis V (2012) Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience. Blood Transfus 10:87–94. https://doi.org/10.2450/2011.0030-11

    Article  PubMed  PubMed Central  Google Scholar 

  4. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101

    Article  CAS  Google Scholar 

  5. Beshay JE, Morgan H, Madden C, Yu W, Sarode R (2010) Emergency reversal of anticoagulation and antiplatelet therapies in neurosurgical patients. J Neurosurg 112:307–318. https://doi.org/10.3171/2009.7.JNS0982

    Article  CAS  PubMed  Google Scholar 

  6. Beynon C, Potzy A, Unterberg AW, Sakowitz OW (2014) Prothrombin complex concentrate facilitates emergency spinal surgery in anticoagulated patients. Acta Neurochir 156:741–747. https://doi.org/10.1007/s00701-014-2032-x

    Article  PubMed  Google Scholar 

  7. Beynon C, Nofal M, Rizos T, Laible M, Potzy A, Unterberg AW, Sakowitz OW (2015) Anticoagulation reversal with prothrombin complex concentrate in aneurysmal subarachnoid hemorrhage. J Emerg Med 49:778–784. https://doi.org/10.1016/j.jemermed.2015.05.032

    Article  PubMed  Google Scholar 

  8. Beynon C, Potzy A, Jungk C, Unterberg AW, Sakowitz OW (2015) Rapid anticoagulation reversal with prothrombin complex concentrate before emergency brain tumor surgery. J Neurosurg Anesthesiol 27:246–251. https://doi.org/10.1097/ANA.0000000000000104

    Article  PubMed  Google Scholar 

  9. Beynon C, Brenner S, Younsi A, Rizos T, Neumann J-O, Pfaff J, Unterberg AW (2019) Management of patients with acute subdural hemorrhage during treatment with direct oral anticoagulants. Neurocrit Care 30:322–333. https://doi.org/10.1007/s12028-018-0635-4

    Article  CAS  PubMed  Google Scholar 

  10. Beynon C, Olivares A, Gumbinger C, Younsi A, Zweckberger K, Unterberg AW (2019) Management of spinal emergencies in patients on direct oral anticoagulants. World Neurosurg 131:e57–e578. https://doi.org/10.1016/j.wneu.2019.07.234

    Article  Google Scholar 

  11. Bower MM, Sweidan AJ, Shafie M, Atallah S, Groysman LI, Yu W (2019) Contemporary reversal of oral anticoagulation in intracerebral hemorrhage. Stroke 50:529–536. https://doi.org/10.1161/STROKEAHA.118.023840

    Article  PubMed  Google Scholar 

  12. Cabral KP, Fraser GL, Duprey J, Gibbons BA, Hayes T, Florman JE, Seder DB (2013) Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding. Clin Neurol Neurosurg 115:770–774. https://doi.org/10.1016/j.clineuro.2012.07.006

    Article  PubMed  Google Scholar 

  13. Carothers C, Giancarelli A, Ibrahim J, Hobbs B (2018) Activated prothrombin complex concentrate for warfarin reversal in traumatic intracranial hemorrhage. J Surg Res 223:183–187. https://doi.org/10.1016/j.jss.2017.11.008

    Article  CAS  PubMed  Google Scholar 

  14. Cartmill M, Dolan G, Byrne JL, Byrne PO (2000) Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies. Br J Neurosurg 14:458–461. https://doi.org/10.1080/02688690050175265

    Article  CAS  PubMed  Google Scholar 

  15. Chai-Adisaksopha C, Hillis C, Siegal DM, Movilla R, Heddle N, Iorio A, Crowther M (2016) Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis. Thromb Haemost 116:879–890. https://doi.org/10.1160/TH16-04-0266

    Article  PubMed  Google Scholar 

  16. Chan K, Bhandari M (2011) Three-minute critical appraisal of a case series article. Indian J Orthop 45:103–104. https://doi.org/10.4103/0019-5413.77126

    Article  PubMed  PubMed Central  Google Scholar 

  17. Chong CT, Lew TWK, Kuperan P, Tan JJE, Tan HL, Kwek TK (2010) Rapid reversal of coagulopathy in warfarin-related intracranial haemorrhages with prothrombin complex concentrates. Anaesth Intensive Care 38:474–480. https://doi.org/10.1177/0310057X1003800310

    Article  CAS  PubMed  Google Scholar 

  18. Dentali F, Marchesi C, Giorgi Pierfranceschi M, Crowther M, Garcia D, Hylek E, Witt DM, Clark NP, Squizzato A, Imberti D, Ageno W (2011) Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis. Thromb Haemost 106:429–438. https://doi.org/10.1160/TH11-01-005

    Article  CAS  PubMed  Google Scholar 

  19. DerSimonian R, Laird N (2015) Meta-analysis in clinical trials revisited. Contemp Clin Trials 45:139–145. https://doi.org/10.1016/j.cct.2015.09.002

    Article  PubMed  PubMed Central  Google Scholar 

  20. Enriquez A, Lip GYH, Baranchuk A (2016) Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants. Europace 18:955–964. https://doi.org/10.1093/europace/euv030

    Article  PubMed  Google Scholar 

  21. Ezekowitz MD, Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, Krause-Steinrauf H, Kurtzke JF, Nazarian SM, Radford MJ (1992) Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 327:1406–1412. https://doi.org/10.1056/NEJM199211123272002

    Article  CAS  PubMed  Google Scholar 

  22. Felton D, Foley EM, Traub SJ, Vodonos A, Ganetsky M (2016) Risk of venous thromboembolism after receiving prothrombin complex concentrate for warfarin-associated intracranial hemorrhage. J Emerg Med 50:1–6. https://doi.org/10.1016/j.jemermed.2015.07.001

    Article  PubMed  Google Scholar 

  23. Frontera JA, Lewin JJ 3rd, Rabinstein AA, Aisiku IP, Alexandrov AW, Cook AM, Del Zoppo GJ, Kumar M, Peerschke EIB, Stiefel MF, Teitelbaum JS, Wartenberg KE, Zerfoss CL (2016) Guideline for reversal of antithrombotics in intracranial hemorrhage: executive summary. A Statement for Healthcare Professionals From the Neurocritical Care Society and the Society of Critical Care Medicine. Crit Care Med 44:2251–2257. https://doi.org/10.1097/CCM.0000000000002057

    Article  PubMed  Google Scholar 

  24. Goldstein JN, Refaai MA, Milling TJJ, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R (2015) Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. Lancet (London, England) 385:2077–2087. https://doi.org/10.1016/S0140-6736(14)61685-8

    Article  CAS  Google Scholar 

  25. Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ (Clin Res Ed) 327:557–560. https://doi.org/10.1136/bmj.327.7414.557

    Article  Google Scholar 

  26. Husted S, De Caterina R, Andreotti F, Arnesen H, Bachmann F, Huber K, Jespersen J, Kristensen SD, Lip GYHH, Morais J, Rasmussen LH, Siegbahn A, Storey RF, Weitz JI (2014) Non-vitamin K antagonist oral anticoagulants (NOACs): no longer new or novel. Thromb Haemost 111:781–782. https://doi.org/10.1160/TH14-03-0228

    Article  CAS  PubMed  Google Scholar 

  27. Huttner HB, Schellinger PD, Hartmann M, Köhrmann M, Juettler E, Wikner J, Mueller S, Meyding-Lamade U, Strobl R, Mansmann U, Schwab S, Steiner T (2006) Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke 37:1465–1470. https://doi.org/10.1161/01.STR.0000221786.81354.d6

    Article  CAS  PubMed  Google Scholar 

  28. Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JPA, Straus S, Thorlund K, Jansen JP, Mulrow C, Catalá-López F, Gøtzsche PC, Dickersin K, Boutron I, Altman DG, Moher D (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162:777–784. https://doi.org/10.7326/M14-2385

    Article  PubMed  Google Scholar 

  29. Jones LM, Deluga N, Bhatti P, Scrape SR, Bailey JK, Coffey RA (2017) TRALI following fresh frozen plasma resuscitation from burn shock. Burns 43:397–402. https://doi.org/10.1016/j.burns.2016.08.016

    Article  PubMed  Google Scholar 

  30. Joseph B, Aziz H, Pandit V, Hays D, Kulvatunyou N, Yousuf Z, Tang A, O’Keeffe T, Green D, Friese RS, Rhee P (2014) Prothrombin complex concentrate versus fresh-frozen plasma for reversal of coagulopathy of trauma: is there a difference? World J Surg 38:1875–1881. https://doi.org/10.1007/s00268-014-2631-y

    Article  PubMed  Google Scholar 

  31. Kalina M, Tinkoff G, Gbadebo A, Veneri P, Fulda G (2008) A protocol for the rapid normalization of INR in trauma patients with intracranial hemorrhage on prescribed warfarin therapy. Am Surg 74:858–861

    Article  Google Scholar 

  32. Khorsand N, Kooistra HAM, van Hest RM, Veeger NJGM, Meijer K (2015) A systematic review of prothrombin complex concentrate dosing strategies to reverse vitamin K antagonist therapy. Thromb Res 135:9–19. https://doi.org/10.1016/j.thromres.2014.11.019

    Article  CAS  PubMed  Google Scholar 

  33. Lankiewicz MW, Hays J, Friedman KD, Tinkoff G, Blatt PM (2006) Urgent reversal of warfarin with prothrombin complex concentrate. J Thromb Haemost 4:963–966. https://doi.org/10.1111/j.1538-7836.2006.01815.x

    Article  Google Scholar 

  34. Leissinger CA, Blatt PM, Hoots WK, Ewenstein B (2008) Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol 83:137–143. https://doi.org/10.1002/ajh.21046

    Article  CAS  PubMed  Google Scholar 

  35. Mačiukaitiene J, Bilskiene D, Tamašauskas A, Bunevičius A (2018) Prothrombin complex concentrate for warfarin-associated intracranial bleeding in neurosurgical patients: a single-center experience. Medicina (Lithuania) 54:1–9. https://doi.org/10.3390/medicina54020022

    Article  Google Scholar 

  36. Majeed A, Eelde A, Agren A, Schulman S, Holmström M (2012) Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy. Thromb Res 129:146–151. https://doi.org/10.1016/j.thromres.2011.07.024

    Article  CAS  PubMed  Google Scholar 

  37. Makris M, Greaves M, Phillips WS, Kitchen S, Rosendaal FR, Preston EF (1997) Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 77:477–480

    Article  CAS  Google Scholar 

  38. Milling TJJ, Refaai MA, Goldstein JN, Schneider A, Omert L, Harman A, Lee ML, Sarode R (2016) Thromboembolic events after vitamin K antagonist reversal with 4-factor prothrombin complex concentrate: exploratory analyses of two randomized, plasma-controlled studies. Ann Emerg Med 67:96–105.e5. https://doi.org/10.1016/j.annemergmed.2015.04.036

    Article  PubMed  Google Scholar 

  39. Nelson KE, Donahue JG, Munoz A, Cohen ND, Ness PM, Teague A, Stambolis VA, Yawn DH, Callicott B, McAllister H (1992) Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections. Ann Intern Med 117:554–559. https://doi.org/10.7326/0003-4819-117-7-554

    Article  CAS  PubMed  Google Scholar 

  40. Parry-Jones AR, Di Napoli M, Goldstein JN, Schreuder FHBM, Tetri S, Tatlisumak T, Yan B, van Nieuwenhuizen KM, Dequatre-Ponchelle N, Lee-Archer M, Horstmann S, Wilson D, Pomero F, Masotti L, Lerpiniere C, Godoy DA, Cohen AS, Houben R, Al-Shahi Salman R, Pennati P, Fenoglio L, Werring D, Veltkamp R, Wood E, Dewey HM, Cordonnier C, Klijn CJM, Meligeni F, Davis SM, Huhtakangas J, Staals J, Rosand J, Meretoja A (2015) Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage. Ann Neurol 78:54–62. https://doi.org/10.1002/ana.24416

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Rizos T, Jenetzky E, Herweh C, Unterberg A, Hacke W, Veltkamp R (2010) Fast point-of-care coagulometer guided reversal of oral anticoagulation at the bedside hastens management of acute subdural hemorrhage. Neurocrit Care 13:321–325. https://doi.org/10.1007/s12028-010-9443-1

    Article  CAS  PubMed  Google Scholar 

  42. Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM (2004) The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 164:880–884. https://doi.org/10.1001/archinte.164.8.880

    Article  CAS  PubMed  Google Scholar 

  43. Santibanez M, Lesch CA, Lin L, Berger K (2018) Tolerability and effectiveness of 4-factor prothrombin complex concentrate (4F-PCC) for warfarin and non-warfarin reversals. J Crit Care 48:183–190. https://doi.org/10.1016/j.jcrc.2018.08.031

    Article  CAS  PubMed  Google Scholar 

  44. Sarode R, Milling TJJ, Refaai MA, Mangione A, Schneider A, Durn BL, Goldstein JN (2013) Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation 128:1234–1243. https://doi.org/10.1161/CIRCULATIONAHA.113.002283

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Sedgwick P, Marston L (2015) How to read a funnel plot in a meta-analysis. BMJ (Clin Res Ed) 351:h4718. https://doi.org/10.1136/bmj.h4718

    Article  Google Scholar 

  46. Spahn DR, Bouillon B, Cerny V, Duranteau J, Filipescu D, Hunt BJ, Komadina R, Maegele M, Nardi G, Riddez L, Samama C-M, Vincent J-L, Rossaint R (2019) The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care 23:98. https://doi.org/10.1186/s13054-019-2347-3

    Article  PubMed  PubMed Central  Google Scholar 

  47. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605. https://doi.org/10.1007/s10654-010-9491-z

    Article  Google Scholar 

  48. Stead LG, Jain A, Bellolio MF, Odufuye AO, Dhillon RK, Manivannan V, Gilmore RM, Rabinstein AA, Chandra R, Serrano LA, Yerragondu N, Palamari B, Decker WW (2010) Effect of anticoagulant and antiplatelet therapy in patients with spontaneous intra-cerebral hemorrhage: does medication use predict worse outcome? Clin Neurol Neurosurg 112:275–281. https://doi.org/10.1016/j.clineuro.2009.12.002

    Article  PubMed  Google Scholar 

  49. Steiner T, Poli S, Griebe M, Hüsing J, Hajda J, Freiberger A, Bendszus M, Bösel J, Christensen H, Dohmen C, Hennerici M, Kollmer J, Stetefeld H, Wartenberg KE, Weimar C, Hacke W, Veltkamp R (2016) Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial. Lancet Neurol 15:566–573. https://doi.org/10.1016/S1474-4422(16)00110-1

    Article  CAS  PubMed  Google Scholar 

  50. Sterne JA, Egger M (2001) Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 54:1046–1055. https://doi.org/10.1016/s0895-4356(01)00377-8

    Article  CAS  PubMed  Google Scholar 

  51. Toth P, van Veen JJ, Robinson K, Maclean RM, Hampton KK, Laidlaw S, Makris M (2013) Real world usage of PCC to “rapidly” correct warfarin induced coagulopathy. Blood Transfus 11:500–505. https://doi.org/10.2450/2012.0113-12

    Article  PubMed  PubMed Central  Google Scholar 

  52. Veritas Health Innovation Covidence systematic review software

  53. Vigué B, Ract C, Tremey B, Engrand N, Leblanc PE, Decaux A, Martin L, Benhamou D (2007) Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage. Intensive Care Med 33:721–725. https://doi.org/10.1007/s00134-007-0528

    Article  PubMed  Google Scholar 

  54. Woo CH, Patel N, Conell C, Rao VA, Faigeles BS, Patel MC, Pombra J, Akins PT, Axelrod YK, Ge IY, Sheridan WF, Flint AC (2014) Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor vii, and prothrombin complex concentrate. World Neurosurg 81:110–115. https://doi.org/10.1016/j.wneu.2012.12.002

    Article  PubMed  Google Scholar 

  55. Yanamadala V, Walcott BP, Fecci PE, Rozman P, Kumar JI, Nahed BV, Swearingen B (2014) Reversal of warfarin associated coagulopathy with 4-factor prothrombin complex concentrate in traumatic brain injury and intracranial hemorrhage. J Clin Neurosci 21:1881–1884. https://doi.org/10.1016/j.jocn.2014.05.001

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Yoshimura S, Sato S, Todo K, Okada Y, Furui E, Matsuki T, Yamagami H, Koga M, Takahashi JC, Nagatsuka K, Arihiro S, Toyoda K (2017) Prothrombin complex concentrate administration for bleeding associated with non-vitamin K antagonist oral anticoagulants: the SAMURAI-NVAF study. J Neurol Sci 375:150–157. https://doi.org/10.1016/j.jns.2017.01.041

    Article  CAS  PubMed  Google Scholar 

  57. Zander AL, Olson EJ, Van Gent J-M, Bandle J, Calvo RY, Shackford SR, Peck KA, Sise CB, Sise MJ, King BS (2015) Does resuscitation with plasma increase the risk of venous thromboembolism? J Trauma Acute Care Surg 78:34–39. https://doi.org/10.1097/TA.0000000000000480

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rania A. Mekary.

Ethics declarations

Conflict of interest

The authors report no disclosures or conflicts of interest.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval

Ethics committee approval was not sought as this study analyzed published data.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Code availability

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Harrison Faulkner and Shubham Chakankar are co-first authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Faulkner, H., Chakankar, S., Mammi, M. et al. Safety and efficacy of prothrombin complex concentrate (PCC) for anticoagulation reversal in patients undergoing urgent neurosurgical procedures: a systematic review and metaanalysis. Neurosurg Rev 44, 1921–1931 (2021). https://doi.org/10.1007/s10143-020-01406-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10143-020-01406-z

Keywords

Navigation